Strategies aimed at reducing embolic events in AF patients include therapy with aspirin, combination of aspirin and clopidogrel, and oral anticoagulation therapy with warfarin or one of the new agents targeting either thrombin or Factor Xa [9–11]. The gene discussed is F10; the disease is atrial fibrillation.